Brief

RegenXBio (RGNX) Gets a Buy Rating from Chardan Capital

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on RegenXBio (RGNX) today and set a price target of $150. The company’s shares …

Synovus (SNV) Gets a Hold Rating from Stephens

In a report released today, Tyler Stafford from Stephens maintained a Hold rating on Synovus (SNV), with a price target of $40. The …

Williams Capital Thinks SM Energy’s Stock is Going to Recover

Williams Capital analyst Gabriele Sorbara reiterated a Buy rating on SM Energy (SM) today and set a price target of $25. The company’s …

H.C. Wainwright Believes Voyager Therapeutics Inc (VYGR) Still Has Room to Grow

In a report released today, Debjit Chattopadhyay from H.C.

Cowen & Co. Sticks to Their Buy Rating for Parsons Corporation (PSN)

Cowen & Co. analyst Cai Rumohr maintained a Buy rating on Parsons Corporation (PSN) today and set a price target of $35.

Maxim Group Thinks Seanergy Maritime’s Stock is Going to Recover

Maxim Group analyst Tate Sullivan maintained a Buy rating on Seanergy Maritime (SHIP) yesterday and set a price target of $4. The company’s …

Stephens Assigns a Buy Rating on Everbridge Inc (EVBG)

Stephens analyst Dmitry Netis assigned a Buy rating to Everbridge Inc (EVBG) today and set a price target of $98. The company’s shares …

H.C. Wainwright Remains a Buy on HTG Molecular Diagnostics (HTGM)

In a report released today, Yi Chen from H.C.

Analysts Offer Insights on Healthcare Companies: Stealth Biotherapeutics Corp (MITO), T2 Biosystems (TTOO) and Forty Seven Inc (FTSV)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stealth Biotherapeutics Corp (MITO), T2 …

GoldMining Inc (GOLD) Gets a Buy Rating from H.C. Wainwright

GoldMining Inc (GOLD), the Materials sector company, was revisited by a Wall Street analyst today. Analyst Heiko Ihle from H.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts